Potential Dilution from the Exercise of Stock Acquisition Rights
First written in FY2017. 11 of 24 entries say "Materialised", first in FY2018-Q2. Latest entry: FY2025.
Sharingtechnology moved to the "Worse" side of this theme in 2018, 3 years before the typical company in this theme (2021).
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
52 other companies' latest entry also says "Mitigated".
- FY2025MitigatedAnnual report
「As of 30 September 2025, the number of potential shares represented by these stock acquisition rights was 1,296,000, equivalent to 5.3% of the total number of issued shares of 24,429,800.」
The percentage of potential shares relative to the total number of issued shares declined from 10.68% in the previous fiscal year to 5.3%. During FY2025, 1,186,000 shares under stock acquisition rights were exercised. - FY2024MitigatedAnnual report
「As of 30 September 2024, the number of potential shares represented by these stock acquisition rights was 2,482,000, equivalent to 10.68% of the total number of issued shares of 23,243,800.」
The percentage of potential shares relative to the total number of issued shares declined from 14.16% in FY2023 to 10.68%. - FY2024-Q2MaterialisedAnnual report
「Total number of issued shares Balance at beginning of period 22,331,700 Increase during the period (Note) 512,600 Balance at end of period 22,844,300 (Note) Due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 512,600 shares during the second quarter consolidated cumulative period, increasing the total number of issued shares from 22,331,700 to 22,844,300. Part of the dilution factor has materialized through actual share issuance. - FY2024-Q1MaterialisedAnnual report
「Total number of issued shares Balance at beginning of period 22,331,700 Increase during the period (Note) 330,700 Balance at end of period 22,662,400 (Note) Due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 330,700 shares during the first quarter consolidated cumulative period, increasing the total number of issued shares from 22,331,700 to 22,662,400. Part of the dilution factor has materialized through actual share issuance. - FY2023WorsenedAnnual report
「As of 30 September 2023, the number of potential shares represented by these stock acquisition rights was 3,163,000, equivalent to 14.16% of the total number of issued shares of 22,331,700.」
The percentage of potential shares relative to the total number of issued shares increased from 11.53% in FY2022 to 14.16%, increasing dilution exposure. Share issuance through the exercise of stock acquisition rights is also continuing. - FY2023-Q3MaterialisedAnnual report
「Total number of issued shares Balance at beginning of period 21,829,600 Increase during the period (Note) 399,200 Balance at end of period 22,228,800 (Note) Due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 399,200 shares during the nine-month consolidated cumulative period, increasing the total number of issued shares from 21,829,600 to 22,228,800. Part of the dilution factor has materialized through actual share issuance. - FY2023-Q2MaterialisedAnnual report
「Increase during the period (Note) — 8,000 (Note) Due to the exercise of stock acquisition rights.」
During the six-month consolidated cumulative period, the exercise of stock acquisition rights increased the total number of issued shares by 8,000, meaning that part of the potential dilution factor materialized through actual share issuance. - FY2023-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
During the first quarter accounting period, the exercise of stock acquisition rights increased the total number of issued shares by 8,000, meaning that part of the potential dilution factor materialized through actual share issuance. - FY2022MitigatedAnnual report
「As of 30 September 2022, the number of potential shares represented by these stock acquisition rights was 2,517,300, equivalent to 11.53% of the total number of issued shares of 21,829,600.」
The percentage of potential shares relative to the total number of issued shares declined from 11.97% in the previous fiscal year to 11.53%. - FY2021MitigatedAnnual report
「As of 30 September 2021, the number of potential shares represented by these stock acquisition rights was 2,612,500, equivalent to 11.97% of the total number of issued shares of 21,818,800.」
While share issuance through the exercise of stock acquisition rights progressed, the percentage of potential shares relative to the total number of issued shares declined from 14.92% in the previous fiscal year to 11.97%. - FY2021-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
During the first quarter accounting period, the exercise of stock acquisition rights increased the total number of issued shares by 560,000, bringing the total to 21,818,800. Part of the potential dilution factor has materialized through actual share issuance. - FY2020WorsenedAnnual report
「As of 30 September 2020, the number of potential shares represented by these stock acquisition rights was 3,172,500, equivalent to 14.92% of the total number of issued shares of 21,258,800.」
The number of potential shares increased from 2,623,900 in FY2019 to 3,172,500, while their percentage of the total number of issued shares increased from 14.25% to 14.92%. - FY2020-Q3WorsenedAnnual report
「Number of shares underlying the stock acquisition rights (shares)* 873,000 (Note 1) Number of shares underlying the stock acquisition rights (shares)* 1,527,000 (Note 1)」
The Twelfth Series of Stock Acquisition Rights covering 873,000 shares and the Eleventh Series covering 1,527,000 shares were newly disclosed, establishing a total of 2,400,000 potential shares. The exercise period for both is from 1 November 2021 to 4 June 2024. - FY2020-Q2MaterialisedAnnual report
「Number of exercise-adjustable stock acquisition rights with bonds during the quarter: 12,200 Number of shares delivered upon exercise during the quarter: 1,220,000 Funds raised through exercise during the quarter: ¥411.650 million」
During the second quarter accounting period, 12,200 of the Tenth Series of Stock Acquisition Rights were exercised, resulting in the issuance of 1,220,000 shares and actual proceeds of ¥411.650 million. The total number of issued shares became 19,627,400. - FY2020-Q1WorsenedAnnual report
「Total number of stock acquisition rights: 34,000 Potential shares resulting from this issuance Potential shares: 3,400,000 shares (100 shares per stock acquisition right)」
Following the resolution to issue the Tenth Series of Stock Acquisition Rights, 3,400,000 potential shares were newly established. This represents approximately 18.5% of the total number of issued shares of 18,407,400. - FY2019MitigatedAnnual report
「As of 30 September 2019, the number of potential shares represented by these stock acquisition rights was 2,623,900, equivalent to 14.25% of the total number of issued shares of 18,407,400.」
While shares continued to be issued through the exercise of stock acquisition rights, the number of potential shares and their percentage of the total number of issued shares declined from 5,334,984 shares and 29.04% in FY2018 to 2,623,900 shares and 14.25%. - FY2019-Q3MaterialisedAnnual report
「1 April 2019–30 June 2019 (Note) 900 18,407,400 91 674,685 91 639,685 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the total number of issued shares by 900 during the third quarter accounting period. In addition, 797,347 dilutive potential common shares were excluded from the calculation for the nine-month period because they had an anti-dilutive effect. - FY2019-Q2MaterialisedAnnual report
「1 January 2019–31 March 2019 (Note) 18,300 18,406,500 1,866 674,593 1,866 639,593 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the total number of issued shares by 18,300 during the second quarter accounting period, meaning that part of the dilution factor materialized through actual share issuance. - FY2019-Q1MaterialisedAnnual report
「1 October 2018–31 December 2018 (Note) 17,100 18,388,200 1,789 672,726 1,789 637,726 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the total number of issued shares by 17,100 during the quarter, meaning that part of the dilution factor materialized through actual share issuance. - FY2018WorsenedAnnual report
「As of 30 September 2018, the number of potential shares represented by these stock acquisition rights was 5,334,984, equivalent to 29.04% of the total number of issued shares of 18,371,100.」
The number of potential shares and their percentage of the total number of issued shares increased from 14.99% reported for FY2018-Q3 to 29.04%. As of the filing date, the percentage is stated as 14.09% after the cancellation of the Seventh Series of Stock Acquisition Rights. - FY2018-Q3WorsenedAnnual report
「Number of shares underlying the stock acquisition rights (shares): 916,000 The number of allotted shares is fixed at 1,000. The total number of shares underlying these stock acquisition rights is 916,000, equivalent to 14.99% of the total number of issued shares.」
A total of 916,000 shares under the Seventh Series of Stock Acquisition Rights, equivalent to 14.99% of the total number of issued shares, were newly issued, increasing dilution exposure. In addition, 4,500 shares were issued through the exercise of stock acquisition rights during the quarter. - FY2018-Q2MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The exercise of stock acquisition rights increased the total number of issued shares by 308,400 during the quarter, meaning that part of the potential dilution materialized through actual share issuance. - FY2018-Q1WorsenedAnnual report
「The stock acquisition rights issued during the first quarter accounting period are as follows. Number of shares underlying the stock acquisition rights (shares): 638,000」
New stock acquisition rights covering 638,000 shares were issued, increasing dilution exposure in addition to the potential shares reported in the previous filing. - FY2017First statedAnnual report
「As of 30 September 2017, the number of potential shares represented by these stock acquisition rights was 385,100, equivalent to 6.6% of the total number of issued shares of 5,801,500.」
The disclosure quantifies the potential dilution from the exercise of stock acquisition rights in terms of potential shares and their percentage.